Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

Jaipur: The Rajasthan government said on Tuesday that an ‘Anti-Narcotics Task Force’ would soon be formed to control the drug menace in the state. State Medical and Health Minister Gajendra Singh informed the members of the Rajasthan Assembly on Tuesday that the increasing trend of drug addiction in the State is a serious issue, and the state government is committed to saving the youth from the clutches of drugs.

He was responding to supplementary questions asked by the member in this regard on behalf of the Home Minister during the Question Hour.

He said the formation of ‘Anti-Narcotics Task Force’ has been announced in the state budget 2024-25. The state government will take strict action against narcotics.

Related Posts

  • Pharma
  • July 10, 2025
  • 103 views
Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

India stands tall as a pharmaceutical powerhouse, supplying 20% of the world’s generic medicines and nearly 62% of global vaccines. Yet, this success now faces a storm: US President Donald…

  • Pharma
  • July 10, 2025
  • 96 views
Novartis wins approval for first malaria drug for newborns and babies

ZURICH: Novartis (NOVN.S), opens new tab said on Tuesday it had received approval in Switzerland for Coartem Baby, which it said was the first drug to treat malaria in babies…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Very Arty Surgery for Weight Loss by SSI Mantra, World’s First

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Pills & Profits: Can India’s pharma sector handle Trump’s planned 200% tariff dose?

Novartis wins approval for first malaria drug for newborns and babies

Novartis wins approval for first malaria drug for newborns and babies

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr

Nectar to sell API, formulations & menthol biz to Ceph Lifesciences for Rs 1,290 cr